Insights into the role of sialylation in cancer progression and metastasis
C Dobie, D Skropeta - British Journal of Cancer, 2021 - nature.com
Upregulation of sialyltransferases—the enzymes responsible for the addition of sialic acid to
growing glycoconjugate chains—and the resultant hypersialylation of up to 40–60% of …
growing glycoconjugate chains—and the resultant hypersialylation of up to 40–60% of …
Role of chemokines in the crosstalk between tumor and tumor-associated macrophages
R Qin, W Ren, G Ya, B Wang, J He, S Ren… - Clinical and …, 2023 - Springer
Tumor microenvironment (TME) consists of a dynamic network of non-tumoral stromal cells,
including cancer-associated fibroblasts, endothelial cells, tumor-associated macrophages …
including cancer-associated fibroblasts, endothelial cells, tumor-associated macrophages …
[HTML][HTML] CXCL12-CXCR4/CXCR7 axis in cancer: From mechanisms to clinical applications
Y Yang, J Li, W Lei, H Wang, Y Ni, Y Liu… - … journal of biological …, 2023 - ncbi.nlm.nih.gov
Cancer is a multi-step disease caused by the accumulation of genetic mutations and/or
epigenetic changes, and is the biggest challenge around the world. Cytokines, including …
epigenetic changes, and is the biggest challenge around the world. Cytokines, including …
Epigenetic modification regulates tumor progression and metastasis through EMT
T Tan, P Shi, MN Abbas, Y Wang… - International …, 2022 - spandidos-publications.com
Epigenetics is the study of heritable molecular determinants that are independent of
phenotypic features. The epigenetic features include DNA methylation, histone …
phenotypic features. The epigenetic features include DNA methylation, histone …
Targeting E-selectin to tackle cancer using uproleselan
Simple Summary This review focuses on eradicating cancer by targeting a surface protein
expressed on the endothelium—E-selectin—with a novel drug, uproleselan (GMI-1271) …
expressed on the endothelium—E-selectin—with a novel drug, uproleselan (GMI-1271) …
CXCR7 as a novel therapeutic target for advanced prostate cancer
G Gritsina, J Yu - Oncogene, 2023 - nature.com
Chemokines and their cognate receptors comprise an intricate signaling network that
becomes high-jacked by cancer cells for uncontrollable tumor growth and dissemination …
becomes high-jacked by cancer cells for uncontrollable tumor growth and dissemination …
Anticancer opportunities at every stage of chemokine function
NVO Zacarías, MP Bemelmans, TM Handel… - Trends in …, 2021 - cell.com
The chemokine system, comprising 48 chemokines and 23 receptors, is critically involved in
several hallmarks of cancer. Yet, despite extensive efforts from the pharmaceutical sector …
several hallmarks of cancer. Yet, despite extensive efforts from the pharmaceutical sector …
Metastasis prevention: How to catch metastatic seeds
TS Gerashchenko, AA Schegoleva… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Despite considerable advances in the evolution of anticancer therapies, metastasis still
remains the main cause of cancer mortality. Therefore, current strategies for cancer cure …
remains the main cause of cancer mortality. Therefore, current strategies for cancer cure …
The involvement of a chemokine receptor antagonist CTCE‐9908 and kynurenine metabolites in cancer development
DS Nkandeu, C Basson, AM Joubert… - Cell Biochemistry …, 2022 - Wiley Online Library
Cancer is the second leading cause of mortality worldwide. Skin cancer is the most common
cancer in South Africa with nearly 20,000 reported cases every year and 700 deaths. If …
cancer in South Africa with nearly 20,000 reported cases every year and 700 deaths. If …
Cadherins, selectins, and integrins in CAM-DR in leukemia
The interaction between leukemia cells and the bone microenvironment is known to provide
drug resistance in leukemia cells. This phenomenon, called cell adhesion-mediated drug …
drug resistance in leukemia cells. This phenomenon, called cell adhesion-mediated drug …